Bacterial vaginosis. Inflammatory diseases of female pelvic organs
Conditions
Interventions
Intervention 1: Intervention group: Vagiclean vaginal tablets. Intervention 2: Control group: Metronidazole vaginal tablets.
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 49 Years
Inclusion criteria
Inclusion criteria: • Women in the age range of 18 to 49 years• Women who are sexually active• Bacterial vaginitis has been diagnosed in them.
Exclusion criteria
Exclusion criteria: • Pregnancy and lactation • The presence of an intrauterine device , Use of specific medications such as immunosuppressive drugs and broad-spectrum antibiotics • Having certain diseases such as liver, nerve, heart, kidney and blood dyscrasias and diabetes Use of antiprostaglandins • Complications from drug use or drug allergies • Vaginal candidiasis and Trichomonas vaginalis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bacterial vaginitis. Timepoint: Before intervention, 5th days of intervention, 10th days of intervention. Method of measurement: Observation of symptoms.;Clinical symptoms (dysuria, itching, lower abdominal pain, burning, dysparonia, foul-smelling discharge, vaginal discharge). Timepoint: Before intervention, 5th days of intervention, 10th days of intervention. Method of measurement: Observation of symptoms.;Positive Amsel criteria (KOH test, PH test, clinical signs, smear test). Timepoint: Before intervention, 5th days of intervention, 10th days of intervention. Method of measurement: results of laboratory symptoms. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dysuria, itching, lower abdominal pain, burning, dysparonia, foul-smelling discharge, vaginal discharge. Timepoint: Before intervention, 5th day of intervention, 10th day of intervention. Method of measurement: Clinical interview with the patient.;Positive Amsel criteria (KOH test, PH test, clinical signs, smear test). Timepoint: Before intervention, 5th day of intervention, 10th day of intervention. Method of measurement: Observation of symptoms. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Akbari
Kashan University of Medical Sciences
Outcome results
None listed